Human TSLP Protein (R127A, R130A), His Tag (MALS verified)
分子別名(Synonym)
TSLP
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human TSLP Protein (R127A, R130A), His Tag (TSP-H5243) is expressed from human 293 cells (HEK293). It contains AA Tyr 29 - Gln 159 (Accession # Q969D9-1 (R127A, R130A)).
Predicted N-terminus: His
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 16.6 kDa. The protein migrates as 20-30 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method / rFC method.
純度(Purity)
>90% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.


背景介紹
胸腺基質(zhì)淋巴細(xì)胞生成素(TSLP)是一種上皮細(xì)胞源性細(xì)胞因子,廣泛表達(dá)于上皮細(xì)胞,參與炎癥性皮膚病的病理過(guò)程。人類TSLP的cDNA可編碼由159個(gè)氨基酸殘基組成的前體蛋白,其中包含28個(gè)氨基酸的信號(hào)序列(4, 5)。研究表明,人類TSLP具有促進(jìn)非刪除性中樞耐受、增強(qiáng)上皮誘導(dǎo)的類別轉(zhuǎn)換、誘發(fā)特應(yīng)性疾病以及維持腸道非炎癥環(huán)境等功能。在響應(yīng)人類TSLP的多種細(xì)胞中,CD11c+樹突狀細(xì)胞是其特征最明確的靶細(xì)胞。
關(guān)鍵字: TSLP;TSLP蛋白;TSLP重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國(guó)生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國(guó)、美國(guó)、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長(zhǎng)期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。